Allergic Contact Dermatitis from Dyes in Wigs Following Diphenylcyclopropenone Treatment

    September 2004 in “ Contact dermatitis
    Sharon M. Crichlow, A P Warin
    Image of study
    TLDR Avoiding dyed wigs and clothing improved severe allergic reactions in a woman treated with diphencyprone.
    A 36-year-old woman with alopecia universalis developed severe allergic contact dermatitis from dyes in wigs following diphencyprone (DPCP) treatment. She experienced severe scalp and generalized eczema without hair regrowth, leading to discontinuation of DPCP. Patch testing revealed a strong reaction to para-phenylenediamine (PPD) in the wig dyes. Despite attempts to use barrier methods and switch to human-hair wigs without dyes, she continued to experience scalp dermatitis. Significant improvement was achieved by avoiding dyed wigs and clothing. This case highlighted the potential for severe allergic reactions to dyes following DPCP treatment, emphasizing the need for careful management of contact allergens in patients undergoing such treatments.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 1000+ results

    Similar Research

    5 / 1000+ results
      British Hair and Nail Society

      research British Hair and Nail Society

      July 2018 in “British Journal of Dermatology”
      Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.
      Update on the Treatment of Alopecia Areata

      research Update on the Treatment of Alopecia Areata

      11 citations, May 2009 in “Actas Dermo-Sifiliográficas”
      Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.
      Drug Armamentarium for Alopecia Areata

      research Drug Armamentarium for Alopecia Areata

      February 2021 in “Journal of pharmaceutical and biological sciences”
      No cure exists for alopecia areata, and treatments are personalized.
      Compounding as a Current Therapeutic Option in Dermatology

      research Compounding as a Current Therapeutic Option in Dermatology

      1 citations, October 2013 in “Actas Dermo-Sifiliográficas”
      Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.